Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [2551]

AACR 2019: Tarloxotinib promising against NRG1-fusion cancers

AACR 2019: Tarloxotinib promising against NRG1-fusion cancers

AACR 2019: Final results from early-phase lung cancer study show combination of Cuban immunotherapy and nivolumab is safe

AACR 2019: Final results from early-phase lung cancer study show combination of Cuban immunotherapy and nivolumab...

AACR 2019: Mesothelin-targeted CAR T-cell therapy shows early promise in patients with advanced solid tumours

AACR 2019: Mesothelin-targeted CAR T-cell therapy shows early promise in patients with advanced solid tumours

AACR 2019: Adding the MET inhibitor savolitinib to osimertinib beneficial for certain pretreated lung cancer patients

AACR 2019: Adding the MET inhibitor savolitinib to osimertinib beneficial for certain pretreated lung cancer...

Origin of resistance to lung cancer drug discovered

Origin of resistance to lung cancer drug discovered

Pushing MYC inhibition closer to the clinic

Pushing MYC inhibition closer to the clinic

Researchers use radiomics to predict which NSCLC patients will benefit from chemotherapy

Researchers use radiomics to predict which NSCLC patients will benefit from chemotherapy

Drug used to control cholesterol found effective against cancer-associated cachexia

Drug used to control cholesterol found effective against cancer-associated cachexia

Researchers develop new method to detect cancerous DNA in lung cancer patients’ blood: an advance in liquid biopsies

Researchers develop new method to detect cancerous DNA in lung cancer patients’ blood: an advance in liquid...

FDA approves atezolizumab for extensive-stage small cell lung cancer

FDA approves atezolizumab for extensive-stage small cell lung cancer

More from ecancer